17 September 2026 · The Pharmacist
Study links cardiovascular disease to increased cancer mortality risk
A long-term study conducted by researchers from the University of Aberdeen and Keele University has identified an association between cardiovascular disease and an increased risk of developing and dying from cancer. Published in the European Heart Journal, the research evaluated health data gathered from 22,534 individuals over a monitoring period spanning more than 25 years.
According to the published findings, people with cardiovascular conditions demonstrated a higher likelihood of receiving a cancer diagnosis and subsequently dying from the disease compared to those without underlying cardiovascular issues. The initial report notes that specific patterns were observed among male participants, although further detailed statistical breakdowns and complete comparative analyses were not fully outlined in the initial reporting.
Because the initial release provides limited specifics regarding the exact biological mechanisms or distinct subgroup outcomes, clinical teams will need to examine the full study text to evaluate the clinical nuances in depth. The study nonetheless underscores the complex relationship between major chronic health conditions over extended patient lifespans.
For UK online pharmacies and digital healthcare brands, these findings suggest clinical teams and prescribing services may eventually need to consider broader multi-morbidity risk factors during patient consultations, though no direct regulatory or operational changes are required at this stage.